Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07820527

TCD and ONSD for Early Risk Stratification of Traumatic Brain Injury

This observational study aims to evaluate the combined use of transcranial Doppler (TCD) and optic nerve sheath diameter (ONSD) ultrasound for early risk stratification of adults with traumatic brain injury (TBI) presenting to the Emergency Department. The study will assess whether ONSD measurements and TCD-derived middle cerebral artery pulsatility index (MCA-PI), in addition to clinical and computed tomography findings, can help identify patients at increased risk of early neurological deterioration. Adult patients with acute TBI and a Glasgow Coma Scale (GCS) score of 13 or less will be enrolled. TCD and ONSD measurements will be performed at emergency department presentation, with repeat measurements at 24 hours when clinically feasible in patients who have not developed early neurological deterioration. The primary outcome is early neurological deterioration within 24 hours.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Traumatic brain injury (TBI) is a major cause of morbidity and mortality and may be complicated by secondary neurological deterioration after the initial injury. Early identification of patients at increased risk of deterioration may facilitate closer monitoring and timely escalation of neurological management.

This prospective observational cohort study will be conducted in the Emergency Department of Assiut University Hospitals. Adult patients aged 18 years or older presenting with acute traumatic brain injury, a baseline Glasgow Coma Scale (GCS) score of 13 or less, and an initial computed tomography (CT) scan demonstrating a traumatic intracranial structural lesion will be considered for inclusion. Patients with an immediate neurosurgical indication, significant orbital trauma or ocular pathology interfering with reliable ONSD measurement, previous decompressive craniectomy, or an inadequate temporal acoustic window preventing reliable MCA-TCD assessment will be excluded.

At baseline, demographic and clinical data, neurological examination findings, GCS, pupillary findings, and CT findings will be recorded. CT severity will be assessed using the Rotterdam CT score. Bilateral optic nerve sheath diameter (ONSD) measurements and transcranial Doppler (TCD) assessment of the middle cerebral arteries will be performed at baseline. MCA pulsatility index (PI) will be the prespecified primary TCD variable for the primary predictive analysis, while other TCD parameters will be recorded as secondary or exploratory variables.

Patients will be followed for 24 hours for the primary outcome of early neurological deterioration (END), defined as a new or worsening neurological abnormality attributable to TBI, including a decrease in GCS of 2 or more points from baseline when clinically assessable, a new pupillary abnormality, or a new focal neurological deficit not present at baseline.

A repeat ONSD and TCD assessment will be performed at 24 hours only in patients who have not developed END before the scheduled assessment and when clinically feasible and safe. If END occurs before 24 hours, the exact time and type of deterioration will be recorded and research ultrasound examinations will be discontinued for that patient. No event-triggered research ultrasound examination will be performed.

Secondary outcomes will include radiological progression on repeat CT within 24 hours when clinically indicated as part of standard care, escalation of neurological management including emergency neurosurgical intervention, external ventricular drainage or other intracranial pressure-directed intervention, and in-hospital mortality. The study procedures will not delay or interfere with standard clinical management.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years or older.
  • Acute traumatic brain injury diagnosed clinically and/or radiologically.
  • Initial Glasgow Coma Scale (GCS) score ≤13.
  • Initial CT brain scan demonstrating a traumatic intracranial structural lesion.
  • No indication for immediate neurosurgical intervention at initial assessment.
  • Initially managed conservatively/non-operatively according to the treating team.
  • Informed consent obtained from the patient or legally authorized representative.

Exclusion criteria

  • Immediate neurosurgical indication requiring urgent intervention.
  • Immediate life-saving procedure or clinical instability preventing safe completion of the research ultrasound assessment.
  • Significant orbital trauma or ocular pathology interfering with reliable optic nerve sheath diameter measurement.
  • Previous decompressive craniectomy.
  • Inadequate temporal acoustic window preventing reliable middle cerebral artery transcranial Doppler assessment.
  • Refusal to participate or withdrawal of consent.

Treatment and study plan

Transcranial Doppler and Optic Nerve Sheath Diameter Assessment

Diagnostic Test

Transcranial Doppler ultrasonography and optic nerve sheath diameter measurement will be performed in eligible patients with traumatic brain injury presenting to the Emergency Department. Baseline measurements will include bilateral optic nerve sheath diameter and middle cerebral artery Doppler parameters, with MCA pulsatility index (PI) prespecified as the primary TCD variable. Repeat measurements at 24 hours will be performed only in patients who have not developed early neurological deterioration and when clinically feasible and safe. These assessments are observational and are used for early risk stratification; no therapeutic intervention is assigned as part of the study. Research procedures will not delay or interfere with standard clinical care.

Primary outcomes

  1. Early Neurological Deterioration (END) within 24 hours

    Time frame: Within 24 hours of Emergency Department presentation

    Early neurological deterioration (END) will be defined as a new or worsening neurological abnormality attributable to traumatic brain injury, including: (1) a decrease in Glasgow Coma Scale (GCS) score of 2 or more points from baseline when clinically assessable; (2) a new pupillary abnormality; or (3) a new focal neurological deficit not present at baseline. END is recorded independently of subsequent escalation of care or neurosurgical intervention.

Secondary outcomes

  1. Radiological progression of traumatic brain injury

    Time frame: Within 24 hours after Emergency Department presentation.

    Radiological progression of traumatic intracranial injury on repeat CT brain imaging within 24 hours, when repeat CT is clinically indicated as part of standard care.

  2. Escalation of neurological management

    Time frame: Within 24 hours after Emergency Department presentation

    Escalation of neurological management within 24 hours, including emergency neurosurgical intervention, external ventricular drainage, or other intracranial pressure-directed intervention.

  3. In-hospital mortality

    Time frame: From Emergency Department presentation until hospital discharge or death, whichever occurs first.

    Death from any cause occurring before hospital discharge.

Study contacts

Contact information is provided by the study sponsor or research team.

Doaa Ellisy, MSc in Emergency Medicine

CONTACT

[email protected]

+201111834281

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Combined Transcranial Doppler and Optic Nerve Sheath Diameter for Early Risk Stratification of Patients With Traumatic Brain Injury in the Emergency Department

Acronym: TCD-ONSD

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Sep 15, 2026
Registry last updated
Sep 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.